KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Receivables - Other: 2009-2021

Historic Receivables - Other for Quest Diagnostics (DGX) over the last 5 years, with Mar 2021 value amounting to $5.0 million.

  • Quest Diagnostics' Receivables - Other changed negligibly% to $5.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $5.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.0 million for FY2020, which is 25.00% down from last year.
  • According to the latest figures from Q1 2021, Quest Diagnostics' Receivables - Other is $5.0 million, which was up 66.67% from $3.0 million recorded in Q4 2020.
  • Quest Diagnostics' Receivables - Other's 5-year high stood at $13.0 million during Q2 2017, with a 5-year trough of $3.0 million in Q4 2017.
  • Its 3-year average for Receivables - Other is $4.1 million, with a median of $4.0 million in 2020.
  • Per our database at Business Quant, Quest Diagnostics' Receivables - Other surged by 83.33% in 2017 and then crashed by 76.92% in 2018.
  • Quest Diagnostics' Receivables - Other (Quarterly) stood at $3.0 million in 2017, then remained steady at $3.0 million in 2018, then soared by 33.33% to $4.0 million in 2019, then dropped by 25.00% to $3.0 million in 2020, then remained steady at $5.0 million in 2021.
  • Its last three reported values are $5.0 million in Q1 2021, $3.0 million for Q4 2020, and $4.0 million during Q3 2020.